Loading clinical trials...
Loading clinical trials...
The Influence of Five Years of Exemestane on Bone Mineral Density in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Conditions
Interventions
biologic sample preservation procedure
dual x-ray absorptometry
Locations
18
United States
Los Angeles Biomedical Research Institute
Torrance, California, United States
The George Washington University
Washington D.C., District of Columbia, United States
Maine Center for Cancer Medicine and Blood Disorders
Scarborough, Maine, United States
Suburban Hospital Cancer Program
Bethesda, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
July 10, 2008
Primary Completion Date
October 31, 2011
Completion Date
January 10, 2013
Last Updated
August 4, 2023
NCT05468034
NCT04541381
NCT03137095
NCT06393374
NCT04852887
NCT07547774
Lead Sponsor
NCIC Clinical Trials Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions